Uromonitor® is a system designed to detect and monitor non-invasive muscle bladder carcinoma by detecting hotspot mutations in the TERT, FGFR3 and KRAS genes by Real-Time PCR from DNA extracted from exfoliated cells present in human urine. - Argentina Medical Device Registration

Access comprehensive regulatory information for Uromonitor® is a system designed to detect and monitor non-invasive muscle bladder carcinoma by detecting hotspot mutations in the TERT, FGFR3 and KRAS genes by Real-Time PCR from DNA extracted from exfoliated cells present in human urine. in the Argentina medical device market through Pure Global AI's free database. This Agile modification of product registration for IVD diagnostics - Group C and D medical device is registered with Argentina's ANMAT (National Administration of Drugs, Food and Medical Technology). The device was registered on July 17, 2024.

This page provides complete registration details including product code (1252-221), brand name (Uromonitor®), authorized representative information, registration type, and regulatory compliance data from the official Argentina ANMAT medical device database. Pure Global AI offers free access to Argentina's medical device registry, helping global MedTech companies navigate Argentina regulations efficiently.